Krish Patel, MD / Nirav Shah, MD, MS - Adapting to Innovation in B-Cell Cancers: Advances With Targeted Therapy and CAR-T and Revisiting the Role of Transplant

About this episode

The episode discusses innovations in B-Cell cancers, focusing on targeted therapies, CAR-T, and the role of transplants.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/WFA865. CME/NCPD/AAPA credit will be available until April 16, 2027. Adapting to Innovation in B-Cell Cancers: Advances With Targeted Therapy & CAR-T and Revisiting the Role of Transplant In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported through independent educational grants from AstraZeneca and Bristol Myers Squibb. Disclosure information is available at the beginning of the video presentation.

People in this episode

Guests: Krish Patel, MD, Nirav Shah, MD, MS

Topics covered

• B-Cell Cancers
• Targeted Therapy
• CAR-T Therapy
• Transplant
• Healthcare Education
• Patient Care

Keywords

• B-Cell Cancers
• Targeted Therapy
• CAR-T
• Transplant
• CME
• Healthcare Education
• Patient Care

Sponsors

AstraZeneca, Bristol Myers Squibb

Mentioned in this episode

Organizations: PeerView Institute for Medical Education, Accreditation Council for Continuing Medical Education, Accreditation Council for Pharmacy Education, American Nurses Credentialing Center

More episodes of PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

• Andrew Kuykendall, MD - Ironing Out the Challenges of PV: Spotlight on Targeting the Hepcidin Pathway for Addressing Unmet Needs and Enhancing Patient Outcomes · June 5, 2026 · 32 min
• Brendon M. Stiles, MD - The Immunotherapy Playbook for Resectable NSCLC: Real-World Challenges and Practical Strategies · June 4, 2026 · 1h 6m
• Luke Maese, DO, Rachel Rau, MD - ADAPT to Advance in ALL/LBL: Achieving Durable Asparaginase Exposure With Personalized Treatment in Pediatric and AYA Patients · May 29, 2026 · 49 min
• Charise Gleason, MSN, NP-C, AOCNP / Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO - “Off-the-Shelf” Choices in RRMM: Oncology Nurse Guidance on Delivering Quality Care With BCMA and Non-BCMA Immunotherapy · May 29, 2026 · 60 min
• Jaume Capdevila, MD, PhD - Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings · May 29, 2026 · 55 min
• Amy E. Armstrong, MD, Angela Hirbe, MD, PhD - ReiNForcing Care Pathways in NF1-PN: Solutions to Improve Outcomes Across the Patient Journey With MEK Inhibition and Shared-Care Models · May 29, 2026 · 1h 5m